Neptune Technologies & Bioressources, Inc. (NASDAQ: NEPT) is a biotechnology company focused on the development and commercialization of products derived from marine biomasses for the nutraceutical and pharmaceutical industries. Leveraging a patented extraction process, the company produces nutrient-rich oils from Antarctic krill, which provide the foundation for its business dealings. Following extraction, Neptune principally sells its krill oils under the NKO® brand through a network of distributors doing business in the U.S., European and Australian nutraceutical markets.
Since bringing its first krill oil product to market in 2003, Neptune has taken significant steps toward increasing its market share in the global nutraceutical industry. The company’s proprietary extraction process allows it to produce an oil with superior levels of EPA, DHA and antioxidants, as compared to other krill oils. As a result, NKO products provide broad, clinically proven support for a collection of health issues. In 2014, Neptune expanded on these benefits by introducing three condition-specific oil blends – including NKO Beat, NKO Focus and NKO Flex – specially formulated to support heart, brain and joint health, respectively.
Last year, Neptune set the stage for continued market growth by launching operations at its new manufacturing facility in Sherbrooke, Quebec. The company’s new plant provides it with the means to address manufacturing challenges unique to krill oil production, affording Neptune an opportunity to optimize operational efficiency while promoting sustainable financial growth. The new facility currently has an annual krill oil production capacity of 150 metric tons, and the company has indicated that expansion efforts could double this capacity in the future.
“Our business has a solid foundation, built on science, intellectual property and entrepreneurship,” Jim Hamilton, president and chief executive officer of Neptune, stated in a news release. “Our key priority is to optimize our plant’s utilization, while producing the industry benchmark krill oil, NKO.”
In the first quarter of 2015, Neptune built on its recent progress by recording strong financial results. In addition to realizing a 10 percent year-over-year increase in revenue for the period, the company made significant headway toward continued improvement by streamlining production processes. For prospective shareholders, these efforts could foreshadow an opportunity to realize considerable returns in the years to come. Look for Neptune to continue expanding its effective production capacity in line with increasing commercial demand moving forward.
For more information, visit www.neptunebiotech.com
